Table 2.
In vivo corneal confocal assessment of patients with obesity (with/without diabetes) compared to age-matched controls.
| Obese Group (pre-diabetic/diabetic) | Obese Group (non-prediabetic/non-diabetic) | Control Group | p* | p | |
|---|---|---|---|---|---|
| Number | 14 | 14 | 20 | – | |
| HbA1c %,mmol/mol, (25%-75% percentiles) | 6.4 (5.97-7.85) | 5.3 (5.2-5.4) | 5.3 (4.9-5.4) | 0.02 | 0.25 |
| CNFD, no./mm2 | 15.9 ± 7.4 | 16.9 ± 8.3 | 28.0 ± 6.5 | 0.73 | <0.001 |
| CNFL, mm/mm2 | 12.0 ± 4.5 | 11.9 ± 4.0 | 16.5 ± 2.9 | 0.95 | <0.001 |
| CNBD, no./mm2 | 39.3 ± 17.6 | 36.8 ± 8.1 | 58.3 ± 11.3 | 0.63 | <0.001 |
Data are presented as mean ± SD for parametric variables and median (25–75% percentiles) for non-parametric variables.
*p-value for comparison of obese subgroups regarding pre-diabetic/diabetic vs. non-prediabetic/non-diabetic
p-value for comparison of obese group (as group 1) with age-matched control group